Blue plastic basket filled with Ozempic dispensers. Photo by Chemist4U CC 2.0

GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people

In the group already struggling with addiction, there were 50% fewer deaths due to substance use among those taking GLP-1 drugs compared with those who were not. We also found 39% fewer overdoses, 26% fewer drug-related hospitalizations and 25% fewer suicide attempts. Over three years, this translated to roughly 12 fewer serious events in total per 1,000 people using GLP-1 drugs – including two fewer deaths.

Continue reading
Overweight obese young women

Making GLP-1 weight loss drugs cheaper isn’t enough to address America’s obesity problem – here’s why

Most patients with obesity and related health problems will likely need to use these medications indefinitely. According to emerging research, people who stop taking them typically regain the weight they lost. Realistically, very few people who take GLP-1 drugs can maintain their weight loss with lifestyle changes alone.

Continue reading
Illustration of a bowl of rice with a spoon to the side.

Single-food ‘mono diets’: are they effective, pointless, or just plain dangerous?

With summer in full swing, many people will be tempted by supposedly miraculous dieting tricks to lose those excess kilos that prevent them from enjoying the perfect physique. Among them are so-called “mono diets”: restrictive regimes that consist of exclusively eating one type of food for a period of time, with the aim of quickly losing weight and “detoxing”.

Continue reading